| Website | navigenics.com |
| @Navigenics | |
| Category | BioTech |
| Phone | (650) 585-7700 |
| memberservice@nav... | |
| Employees | |
| Founded | 2006 |
| TOTAL | $43M |
| FUNDING TOTAL | $43M |
| Venture Round, 11/07 Mohr Davidow Ventures Kleiner Perkins Caufield & Byers Sequoia Capital | $25M |
| Series C, 2/10 Procter & Gamble Kleiner Perkins Caufield & Byers Mohr Davidow Ventures | $18M |
Navigenics, Inc. helps educate and empower individuals and their physicians with knowledge of their genetic predispositions, and then motivates them to act on the information to prevent the onset of disease, achieve earlier diagnosis, appropriately manage disease, or otherwise lessen its impact. Navigenics’ lead investors are Kleiner Perkins Caufield and Byers, Sequoia Capital and MDV-Mohr Davidow Ventures.
